awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38733768-814DBBC4-6CAB-41CD-88E9-D30BC30E4392
Q38733768-814DBBC4-6CAB-41CD-88E9-D30BC30E4392
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38733768-814DBBC4-6CAB-41CD-88E9-D30BC30E4392
Tyrosine Kinase Inhibitors in the Treatment of Systemic Sclerosis: The Difficulty in Interpreting Proof-of-Concept Studies.
P2860
Q38733768-814DBBC4-6CAB-41CD-88E9-D30BC30E4392
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38733768-814DBBC4-6CAB-41CD-88E9-D30BC30E4392
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0dd9128aaef63f9f14d30f85d9837e220b1036d9
P2860
Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate.